The brown seaweed, Turbinaria ornata belongs to Phaeophyceae family was collected from Mandabam district, Tamilnadu. They were cleansed two or three times with sea water followed by fresh water ABSTRACT Aim/Background: The present work was carried out to identify some of the bioactive components present in the Brown seaweed Turbinaria ornata by GC-MS technique, and to ascertain its medicinal properties. Materials and Methods: GC-MS analysis of some of the potent volatile constituents present in the pet ether of Turbinaria ornata was performed. MD simulations were performed for complex structures of human secretory PLA2 and P38 kinase. GC-MS chromatogram showed peaks indicating the presence of various compounds of interest. The interpretation of the mass spectrum of GC-MS was done using the Database of Indian Institute of Crop Processing Technology (IICPT). Twenty compounds were identified in pet ether extract of Turbinaria ornata. All 20 compounds were screened using PASS online activity prediction server, for the possession of anti-inflammatory potency and the selected target proteins were subjected to molecular docking studies. MD simulations were also performed for the top listed compound 16 which was identified from D3P extract (2,3-Diphenylcyclopropyl)methyl phenyl sulfoxide, trans-). Similarly, the complex structure of PLA2 (phospho-ethanolamine, PE) and P38 kinase (3-(2-pyridine-4-ylethyl)-1H-indole) were simulated for comparative study. Results and Conclusion: Based on the in silico results, the binding affinities for compounds of T. ornata were judged against known standards for its capability to restrain inflammation and to promote possibility for scheming potential antiinflammatory lead from natural compounds were discussed.
INTRODUCTION
Allergic and inflammatory diseases are the most familiar diseases all around the world. The prevalence, severity, and complexity of these diseases are getting increased rapidly. Although the many synthetic drugs have given rise to remarkable successes in the progress of novel anti-inflammatory and anti-allergic drugs, the continuous use has led to the miscellaneous and objectionable side effects. Meanwhile, the apparent usage of natural products in the management of these diseases has yet to be fully explored. For the last several thousand years, Mankind recognized that marine organisms contain substances accomplished with potent biological activity. Only recently, the serious investigation of seaweeds was started to say, only half a century ago. Currently, vital pharmacological and therapeutic products are being acquired and dynamically sought from the sea. 1, 2 Among the seaweeds, brown algae represent a rich source of many components like laminarins, fucoidans, and also alginic acids. 3 Moreover, from the ancient time's seaweeds have been used in various fields like medicine, agriculture, etc., 4 Our present study is focused on the brown seaweed Turbinaria ornata, a widespread species belonging to Phaeophyceae, which is rich in fucoids and sulfated polysaccharides 5, 6 and other components like phlorotannins, flavonoids, tannins, glycosides, etc. Turbinaria ornata has been earlier accounted for its antioxidant, anti-inflammatory, and cytotoxicity activity on murine melanoma and colon cancer. [7] [8] [9] But there have not been many reports on the bioactive components responsible or which supports their biological activity. Hence, the present communication deals with the Gas chromatography-Mass spectrometry (GC-MS) analysis of pet ether and chloroform extracts of marine seaweed Turbinaria ornata and molecular docking studies of identified compounds along with known synthetic standard using Schrödinger maestro for its ability to suppress inflammation and to evaluate its antidiabetic potency and further possibility for designing of potential anti-inflammatory and anti-diabetic lead from natural compounds were discussed. Phospholipase A2, human secretory phospholipase A2, and p38alpha MAP kinase are the enzymes focused in this study for the anti-inflammatory activity. These enzymes are the starting material for the inflammatory process which makes it an ideal target for the anti-inflammatory drugs. To the best of our knowledge, this is the first report on GC-MS analysis of pet ether extract of T. ornata and in-silico docking studies of its active constituents. [10] [11] [12] to remove debris or intact sand particle. The samples were dried out in the shade and milled in a mechanical grinder to reduce its particle size. About 25 g of powder was transferred to Schott-Duran bottles and around 250 ml of pet ether in the ratio of 1:10 were added, and the contents of the bottle were stirred continuously at room temperature for two days, and then the extract was filtered, and the solvent is separated by using simple distillation method. The concentrated extract was collected and evaporated at room temperature. It is then submitted to GC-MS examination.
GC-MS Inquisition
The GC-MS analysis was carried out as per the standard method. 10 Gas chromatography was done using Perkin-Elmer GC Clarus 500 system and Gas Chromatograph interfaced to a Mass Spectrophotometer (GC-MS) equipped through Elite-5MS fused silica capillary column (30 m x 0.25 mm x 0.2 μm) composed of 5% diphenyl/95% dimethylpolysiloxane. For GC-MS detection, ionizing energy of 70eV was used using an electron ionization system. The carrier gas used was Helium gas (99.999%) at a constant flow rate of 1 ml/min, and 2 μl of the sample was injected with a split ratio of 10:1; injector temperature was set at 250°C. The oven temperature was planned from 110°C (isothermal for 2min) with a rise of 100°C/min to 200°C, then 5°C/ min to 280°C, ending with a 9 min isothermal at 280°C. Mass spectra were taken at 70eV; 200°C of inlet line source temperature a scanning interval of 0-2 min and mass scan starting from 45 to 450 (m/Z). Entire GC operation time was 36 minutes. The relative % amount was calculated by matching its peak area to the total areas. To handle mass spectra and chromatogram the Software adopted was Turbo mass (Version 5.2). 
Components predicted using GC-MS analysis

Computational methods
Identification of the target proteins
We have used the PASS (prediction of activity spectra for substances) server to find the probable target proteins for each of the 20 compounds based on the score. It predicts more than 300 pharmacological effects and enzymatic mechanism base on the structural formula of the compound of interest. It returns a table of biological activities with corresponding probability values. To calculate the activity, we submitted a standard Mol file of each compound drawn using the Chemsketch software.
Steps involved in docking studies
Molecular docking 13 and dynamics studies are the procedure by which two molecules mingle together in a 3D space and are essential tools in structural biology and computer-aided drug design. [14] [15] [16] In this present study, molecular docking was carried out using Schrodinger software, and the simulations were carried out using AMBER software.
Preparation of protein and ligand
The 3D structure of P38alpha Map kinase (PDB ID: 1W84), human secretory phospholipase A2 from inflammatory exudates (PDB ID: 1POE) and Phospholipase A2 (PDB ID 1FV0) were retrieved from the PDB to validate anti-inflammatory potency of the 20 identified compounds. Using the tool "Protein Preparation Wizard, " the above said proteins were prepared for the computational studies. It includes adding hydrogen atoms and atomic charges, removing water molecules, optimization of hydrogen bond network and energy minimization to remove clashes and strained bonds and angles with 0.30Å RMSD convergence criterion. Addition of hydrogen atoms and correction of bond orders were made for each of the inhibitor presents within the active site without disturbing the bound conformation dictated by the crystal structure. On the other hand, 20 newly identified compounds and the co-crystallized ligands were optimized and performed energy minimization using Ligprep. These Twenty compounds (ligands) were identified by GC-MS interrogation from pet ether extract of T. ornata. The structures of the documented ligand molecules were reclaimed from the PubChem database, and few were drawn using CHEMSKETCH (ACDLABS 12.0)
Induced fit docking (IFD)
Based on the PASS biological activity prediction results of the compounds listed in Table 1 , it was subjected to XP docking studies using Glide module (Schrodinger suite). 17 The top listed compounds based on their docking score and glide energy were subjected for IFD to find their mode of interaction with each of the selected target proteins, Phospholipase A2 (1FV0), human secretory phospholipase A2 (1POE) and p38alpha MAP kinase (1W84). The receptor grid was generated based on the actiPhospholipase A2 (1FV0), e site amino acids for docking. We have employed IFD(3) which introduces the flexibility in both ligand and protein during docking. This was achieved by combining several iterations of docking of the flexible ligand into a rigid receptor followed by the refinement of the active site of the protein to adopt the conformation suitable for a given ligand. In the first step, an ensemble of poses is generated using rigid docking. Next, the sampling of confirmation of protein for each pose generated was in the first step. Third, the re-docking of the ligand into the optimized protein conformation (hence, induced-fit) was carried out. Finally, along with receptor strain and solvation terms, the binding energy associated with each pose was used for scoring.
MD simulations and binding free energy calculation
The complex structures were simulated for 50 ns each to calculate the binding free energy using MM-GBSA method 18 and each simulation system was systematically prepared using Leap module of the AMBER10 suite. 19 The force field parameters for vitamin E, indomethacin and the shortlisted compounds were derived using the antechamber program and general amber force field (GAFF). 20 The atomic point charges were assigned using the AM1-BCC charge method. 21, 22 Finally, the solute molecule was solvated and energy minimization was performed in two phases using Steepest Descent (SD) and Conjugate Gradient (CG) methods. In the first phase, the solvent molecules were relaxed, and all the atoms of protein were restrained by a harmonic potential with force constant (kcal/mol-Å2) using SD and CG methods. The final phase employs the CG method to relax the whole system with unrestrained protein. The successive equilibration process was divided into two stages. In the first stage, the temperature was stabilized around 300 K using Berendsen temperature coupling 23, 24 to ensure the canonical ensemble (NVT) of the system with constant volume and with no pressure coupling whereas, in second stage the pressure was stabilized around 1 atm using isotropic positional scaling with a time constant for pressure coupling, 2 ps with same velocity as first stage. In both the stages, the simulations were run with a time step of 2 fs, the bonds involving hydrogen atom were constrained using SHAKE algorithm 24 and the non-bonded interaction cut-off was set to 10 Å. The Particle Mesh Ewald (PME) method 25 was used to treat the longrange electrostatic interactions. After the equilibration, the system was analyzed in terms of the potential, kinetic and total energy. The ff03 26, 27 all-atom force field was used in all the steps and the binding free energies (ΔG°) were calculated for all the selected hit molecules using MM-GB/SA. [28] [29] [30] The molsurf 31 program was employed to compute both the hydrophobic contribution (through SASA) and electrostatic contribution for solvation free energy. The calculation was performed for the last 2 ns of the trajectory using the mmpbsa.py. 32
RESULTS
Gas chromatography and mass spectroscopy (GC-MS)
The name of the components, its molecular mass, and structures was determined and listed in Table 1 . Docking analysis of components identified in D3-P extract against PDB ID: 1FV0 (Phospholipase A2)
Molecular docking analysis
The Docking simulation technique was carried out using Glide module (Schrodinger suite) with the Compound No. 1, 2, 3, 4, 6, 8, 9, 10, 14, 16, 18 and 20 against Phospholipase A2 (PDB ID 1FV0) and the Glide docking XP results were tabulated in Table 2 and the top listed 3 compounds, i.e., Compound No. 16,10 and 18 were subjected to Induced fit docking, the results were positioned in Table 3 and Figure 2 . Interactions between Phospholipase A2 (PDB ID: 1FV0) and the ligands are depicted using Pymol and Ligplot. 2(a) and 2(c) depicts binding of CID_16 whereas 2(b) and 2(d) depicts the binding of CID_18, respectively whereas 2(e) and 2(f) depicts Interactions between human secretary PLA2 and Cocrystal. The Ligplot image is generated using Ligplot plus version 1.4.5.
Molecular Docking analysis of components identified in D3-P extract against PDB ID: 1POE (Human Secretory Phospholipase A2)
Similarly the Docking simulation technique was carried out for the Compounds 1-4,8-10,14, and 16-20 against Human Secretory Phospholipase A2 (PDB ID 1POE) and the Glide docking XP results were tabulated in Table 4 and the top listed 3 compounds, i.e., Compound No. 17, 16 and 18 were subjected to Induced fit docking, the results were positioned in Table 5 and Figure 3 : Interactions between human secretary PLA2 and the ligands are depicted using Pymol and 
Molecular Docking analysis of components identified in D3-P extract against PDB ID: 1W84 (Human P38 Alpha map kinase)
The same list of components which was screed in PASS server for antiinflammatory activity (Compounds 1-, 4,6,8-10,14,16-18 and 20) were also Docked with Human P38 Alpha map kinase (PDB ID 1 W84), and the Glide docking XP results were tabulated in Table 6 and the top listed 3 compounds, i.e., Compound No. 16,18 and 17 were subjected to Induced fit docking, the results were positioned in Table 7 and the pymol interaction view and Ligplot image of CID_16 was put on view in Figure: 
Molecular dynamics simulation study
Since the percentage peak area of the compound no: 16 is more ( Together, the results confirm that the compound 16 binding both PLA2 and p38k with more affinity compared to the respective co-crystallized ligands. Further analyses based on the binding free energy (ΔG°) also substantiates the above observations. Figure 7 clearly shows that the compound 16 binds more stable.
DISCUSSION
The crude powder was extracted with the solvent Pet ether, and the extract was analyzed using GC-MS technique to get out of the list of the pet ether soluble constituents among which some of the components are with excellent anti-inflammatory activity based on literature review. It is also confirmed by submitting the list of components in the PASS server for its activity affirmation. These components were docked against anti-inflammatory targets using the software; Schrodinger aided drug design software, Maestro. The results of the GC-MS analysis and its chromatogram were exposed in Table 1 and Figure  1 respectively. The results of the interaction between the ligands and protein are shown in pymol and lipgloss view. Glide docking Xp results of the constituents identified in the D3-P extract against PDB ID: 1FV0 showed that compound 18, 16 and ten were having good docking score and Glide energy. Hence, therefore, they were subjected to induce fit Docking (IFD Similarly in the case of D3P extract components against Human Secretory Phospholipase A2 (PDB ID: 1POE) compound no: 16, 18 and 17 are top listed based on their docking score and glide energy. Henceforth they submitted for IFD against the same target. The result revealed that Compound 18: Docecane,2,6,10-trimethyl-has good affinity with the target Human Secretory Phospholipase A2, since its Glide energy and Docking score of the compound 16 are -47.78 and -5.428716 and values of co-crystal are -71.73 and -12.60, respectively. The hydrogen bond length with amino acid HIS-47 is 2.9 for compound 16 and 2.6 for co-crystal. Although the same constituents were also docked with another inflammatory target Human P38 Alpha map kinase with PDB ID: 1W84. This time also the same three top listed compounds Compound 16, 17 and 18 were submitted for IFD, but Compound 17: Heptacosane which was shortlisted in the XP results but its Induced fit docking results didn't show any interaction with the amino acid in which co-crystal had.
Thus compound:16: (2,3-Diphenylcyclopropyl)methyl phenyl sulfoxide, trans-and Compound 18: Docecane,2,6,10-trimethyl-which has good interaction with the selected protein with the same amino acid like that of co-crystal may be responsible solely or in combination with other constituents for its anti-inflammatory activity. Although proper in-vitro and in-vivo testing is required for its activity substantiation.
CONCLUSION
The growing interest in marine-derived anti-inflammatory compounds, along with the development of new technology in marine cultures and extraction will significantly expedite the current exploration of the marine environment for compounds with significant pharmacological applications, which will continue to be a promising strategy and new trend for modern medicine. Future studies on bio-guided fractionation, isolation, and characterization of the selected compounds from these species as well as proper in-vitro and in-vivo testing from these species are needed and are already in process.
